Back to all news

Sybil AI Model Accurately Predicts Lung Cancer Risk in Diverse Urban Populations

EurekAlertResearch

A new study validates the Sybil AI model for predicting lung cancer risk using low-dose CT in a predominantly Black cohort at an urban safety-net hospital.

Key Details

  • 1Study presented at the 2025 IASLC World Conference on Lung Cancer.
  • 2Validation conducted at UI Health on 2,092 baseline low-dose CT scans from 2014-2024.
  • 3Cohort primarily Non-Hispanic Black (62%), with 13% Hispanic and 4% Asian.
  • 4Sybil demonstrated strong Area Under the Curve (AUC): 0.94 (1 yr), 0.90 (2 yr), 0.86 (3 yr), 0.85 (4 yr), 0.80 (5 yr), 0.79 (6 yr).
  • 5Results remained strong after restricting to Black participants and excluding recent diagnoses.
  • 6The Sybil Implementation Consortium will advance to prospective clinical trials for clinical workflow integration.

Why It Matters

Demonstrating reliable AI performance in racially and socioeconomically diverse settings is crucial for equitable lung cancer screening. This validation may facilitate broader adoption and help address longstanding disparities in lung cancer outcomes.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.